Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tiny bundles seek and destroy breast cancer cells

24.05.2005


Penn State College of Medicine study shows for the first time in an animal model that ceramide, a naturally occurring substance that prevents the growth of cells, can be administered through the blood stream to target and kill cancer cells.

"Ceramide is the substance that accumulates in cancer tissues and helps to kill cancer cells when patients undergo chemotherapy and radiation," said Mark Kester, Ph.D., professor of pharmacology, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center. "By boosting the amount of ceramide through an injection in the bloodstream, our study in mice suggests that we can provide a stronger cancer-killing therapy without additional side effects."

This study titled "Systemic Delivery of Liposomal Short-Chain Ceramide Limits Solid Tumor Growth in Murine Models of Breast Adenocarcinoma" was published in the May issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.



Administering extra ceramide is not as easy as it seems. Injected directly into the bloodstream, ceramide is toxic. But Kester applied knowledge gained from previous laboratory studies in nanotechnology and encapsulated the ceramide in tiny bundles called liposomes. "The major problem with ceramide is that it is a lipid and therefore is not soluble in the systemic circulation," Kester said. "Packaging ceramide in our nano liposome capsules allows them to travel through the bloodstream without causing toxicity and release the ceramide in the tumor."

Although the mechanism remains unknown, ceramide is inherently attracted to tumor cells. The liposome-encased ceramide travels through the bloodstream to the tumor where it enters the tumor cells through the tumor’s leaky vasculature. The ceramide disrupts the mitochondria, which act as the energy producer for the cell. This causes apoptosis, or cell death. The ceramide also reduces the vascular network that feeds the tumor. In this study in mice, the ceramide bundles targeted and destroyed only breast cancer cells, sparing the surrounding healthy tissue.

Kester and his team first tested the ceramide-filled liposomes in a culture of breast cancer cells. The administration of ceramide reduced by more than 50 percent the number of breast cancer cells. Additional cell culture studies showed that ceramide accumulated in the mitochondria of the breast cancer cells supporting earlier laboratory studies that ceramide interferes with the structure of the cell and causes tumor death.

In a mouse model of breast tumors, the team administered liposome-encased ceramide every other day via intravenous injection. After 21 days, the mice treated with the liposome-encased ceramide had a six-fold lower tumor volume than the mice treated with "empty" liposomes. The weight of animals treated with ceramide did not vary significantly from the mice treated with empty liposomes signifying that the ceramide was not toxic (weight would have been lower with toxicity). When the tumors were examined, those treated with ceramide showed a 20-fold increase in cellular apoptosis and a 40 percent decrease in cellular proliferation, or growth, compared to the control group.

"Although we’ve shown that ceramide has an effect on breast tumor cells in mice, breast cancer cells in humans may eventually resist the treatment, suggesting that ceramide should be used in combination with more traditional cancer treatments as a treatment booster," Kester said. "Our next step is to explore how additional chemotherapeutic agents could be incorporated into the liposomes for a more lasting effect."

Other study team members were: Thomas C. Stover, Ph.D., Arati Sharma, Ph.D., Department of Pharmacology, and Gavin P. Robertson, Ph.D., Departments of Pharmacology, Pathology, and Dermatology, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center. All research methods were approved by the Animal Care and Use Committee of Penn State College of Medicine. This study was supported by a grant from the National Institutes of Health.

Valerie Gliem | EurekAlert!
Further information:
http://www.psu.edu

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>